Cancer
By the time you are referred to our group for your cancer diagnosis, you will have learned a lot about your specific disease. We know you are faced with the unknown, but assure you our surgeons are well trained and educated in the many fields of cancer surgery. In addition, we offer the expertise of a surgical oncologist, Dr Giovanni Begossi.
We deal with multiple cancer diagnoses including colon, rectal, gastric, esophageal, breast, thyroid, pancreas, liver, gallbladder, skin and soft tissue including melanoma.
East Bay patients suffering from cancer now have new therapy options available in the community. These therapies deliver promising outcomes for patients diagnosed with advanced colorectal or appendiceal malignancies, limb-based skin tumors or soft tissue tumors.
First Surgical Consultants is pleased to offer these new services and to introduce Dr. Begossi, who performs these new therapies.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is indicated for locally recurrent or advanced colorectal or appendiceal malignancies confined to the abdomen. HIPEC is a combination of:
1. Cytoreduction and tumor debulking
2. Administration of intraoperative intraperitoneal heated chemotherapy
1. Drug concentration in the abdomen is 20 to 600 times higher compared with systemic infusion.
2. Concomitant use of heat increases drug permeability in tumor cells.
3. Completeness of cytoreduction is associated with remarkable outcomes.
4. Depending on tumor biology tumor may recur. HIPEC can be readministered, maintaining outcome benefit.
Perioperative Brachytherapy
Management of resectable soft tissue tumor
Administration of brachytherapy in the perioperative therapy may help to prevent recurrence of the disease.
Treatment Programs for Limb Infusion (coming soon)
We will soon feature treatment programs for Limb Infusion -- the Intra-arterial administration of chemotherapy for skin tumors confined to the limb.
Patient benefits include:
1. Drug concentration in the limb is higher compared with systemic infusion
2. Response rate to this technique is as high as 50%, slowing the progression of the disease
3. Limb infusion can be repeated.